目的:探讨康复治疗对脑卒中患者心脏功能的影响。方法:选取2022年8月至2023年8月在陕西省人民医院康复医学科住院的脑卒中患者51例,按治疗方案的不同,分为常规干预组和联合干预组,均给予常规药物治疗,联合干预组在常规治疗的基础上联合...目的:探讨康复治疗对脑卒中患者心脏功能的影响。方法:选取2022年8月至2023年8月在陕西省人民医院康复医学科住院的脑卒中患者51例,按治疗方案的不同,分为常规干预组和联合干预组,均给予常规药物治疗,联合干预组在常规治疗的基础上联合康复治疗,干预时间均为21天。常规干预组25例,其中男16例,女9例,年龄58~73岁;联合干预组26例,其中男15,女11例,年龄60~72岁。比较两组患者治疗前和治疗完成后的B型利钠肽(BNP)、左室射血分数(LVEF)、心脏搏出量(SV)、左室流出道内径(LOVT)、心率、心肌损伤标志物、C反应蛋白(CRP)。结果:两组患者的BNP、心脏射血分数、心脏搏出量、CRP较治疗前均有改善(P Objective: To investigate the effect of rehabilitation therapy on cardiac function in patients with stroke. Methods: A total of 51 stroke patients hospitalized in the Department of Rehabilitation Medicine of Shaanxi Provincial People’s Hospital from August 2022 to August 2023 were selected. According to the different treatment plans, they were divided into conventional intervention group and combined intervention group. Both groups were given conventional drug treatment, and the combined intervention group was given standard rehabilitation treatment on the basis of drug treatment. There were 25 patients in the routine intervention group, including 16 males and 9 females, aged 58~73 years;there were 26 patients in the combined intervention group, including 15 males and 11 females, aged 60~72 years. The levels of B-type natriuretic peptide (BNP), left ventricular ejection fraction (LVEF), cardiac stroke volume (SV), left ventricular outflow tract diameter (LOVT), heart rate, myocardial injury markers, and C-reactive protein (CRP) were compared between the two groups before and after treatment. Results: The improvement of BNP, cardiac ejection fraction, cardiac stroke volume and C-reactive protein in the combined intervention group was better than that in the control group after treatment (P < 0.05). Conclusion: The rehabilitation program of stroke not only treats the primary disease and dysfunction, but also brings a positive impact on the heart function of patients, which can avoid cardiac function damage, prevent the occurrence and development of cardiovascular diseases, reduce risk factors, and improve prognosis.展开更多
目的探讨曲克芦丁联合高频电疗法治疗缺血性脑卒中患者的疗效并检测血清中miR-137及miR-155表达水平。方法2019至2021年在我院接受治疗的缺血性脑卒中患者,分为对照组和观察组,分别采用曲克芦丁和曲克芦丁联合高频电疗法进行治疗。对治...目的探讨曲克芦丁联合高频电疗法治疗缺血性脑卒中患者的疗效并检测血清中miR-137及miR-155表达水平。方法2019至2021年在我院接受治疗的缺血性脑卒中患者,分为对照组和观察组,分别采用曲克芦丁和曲克芦丁联合高频电疗法进行治疗。对治疗前后患者静脉采血采用RT-PCR检测miR-137和miR-155表达水平,对患者进行美国国立卫生研究院卒中量表(National Institutes of Health Stroke Scale,NIHSS)评分和巴氏指数(Barthel index)统计,并分析两者相关性。结果治疗后两组患者外周血miR-137表达水平升高,miR-155表达水平降低,其中观察组患者变化幅度更大。观察组治疗后,NIHSS评分显著低于对照组,巴氏指数显著高于对照组(P<0.05)。相关性分析结果表明,miR-137表达水平与NIHSS评分呈负相关,与巴氏指数呈正相关;miR-155表达水平与NIHSS评分呈正相关,与巴氏指数呈负相关。观察组总有效率高于对照组,不良反应发生率低于对照组。结论曲克芦丁联合高频电疗能改善缺血性脑卒中患者的神经损伤。展开更多
文摘目的:探讨康复治疗对脑卒中患者心脏功能的影响。方法:选取2022年8月至2023年8月在陕西省人民医院康复医学科住院的脑卒中患者51例,按治疗方案的不同,分为常规干预组和联合干预组,均给予常规药物治疗,联合干预组在常规治疗的基础上联合康复治疗,干预时间均为21天。常规干预组25例,其中男16例,女9例,年龄58~73岁;联合干预组26例,其中男15,女11例,年龄60~72岁。比较两组患者治疗前和治疗完成后的B型利钠肽(BNP)、左室射血分数(LVEF)、心脏搏出量(SV)、左室流出道内径(LOVT)、心率、心肌损伤标志物、C反应蛋白(CRP)。结果:两组患者的BNP、心脏射血分数、心脏搏出量、CRP较治疗前均有改善(P Objective: To investigate the effect of rehabilitation therapy on cardiac function in patients with stroke. Methods: A total of 51 stroke patients hospitalized in the Department of Rehabilitation Medicine of Shaanxi Provincial People’s Hospital from August 2022 to August 2023 were selected. According to the different treatment plans, they were divided into conventional intervention group and combined intervention group. Both groups were given conventional drug treatment, and the combined intervention group was given standard rehabilitation treatment on the basis of drug treatment. There were 25 patients in the routine intervention group, including 16 males and 9 females, aged 58~73 years;there were 26 patients in the combined intervention group, including 15 males and 11 females, aged 60~72 years. The levels of B-type natriuretic peptide (BNP), left ventricular ejection fraction (LVEF), cardiac stroke volume (SV), left ventricular outflow tract diameter (LOVT), heart rate, myocardial injury markers, and C-reactive protein (CRP) were compared between the two groups before and after treatment. Results: The improvement of BNP, cardiac ejection fraction, cardiac stroke volume and C-reactive protein in the combined intervention group was better than that in the control group after treatment (P < 0.05). Conclusion: The rehabilitation program of stroke not only treats the primary disease and dysfunction, but also brings a positive impact on the heart function of patients, which can avoid cardiac function damage, prevent the occurrence and development of cardiovascular diseases, reduce risk factors, and improve prognosis.
文摘目的探讨曲克芦丁联合高频电疗法治疗缺血性脑卒中患者的疗效并检测血清中miR-137及miR-155表达水平。方法2019至2021年在我院接受治疗的缺血性脑卒中患者,分为对照组和观察组,分别采用曲克芦丁和曲克芦丁联合高频电疗法进行治疗。对治疗前后患者静脉采血采用RT-PCR检测miR-137和miR-155表达水平,对患者进行美国国立卫生研究院卒中量表(National Institutes of Health Stroke Scale,NIHSS)评分和巴氏指数(Barthel index)统计,并分析两者相关性。结果治疗后两组患者外周血miR-137表达水平升高,miR-155表达水平降低,其中观察组患者变化幅度更大。观察组治疗后,NIHSS评分显著低于对照组,巴氏指数显著高于对照组(P<0.05)。相关性分析结果表明,miR-137表达水平与NIHSS评分呈负相关,与巴氏指数呈正相关;miR-155表达水平与NIHSS评分呈正相关,与巴氏指数呈负相关。观察组总有效率高于对照组,不良反应发生率低于对照组。结论曲克芦丁联合高频电疗能改善缺血性脑卒中患者的神经损伤。
